CB Therapeutics Advances Its Intellectual Property Portfolio for Its Cellular Agriculture Platform with New Patent Applications
SAN DIEGO–(BUSINESS WIRE)–CB Therapeutics is a leading synthetic biotechnology company focused on the research and development of cellular agriculture for the production of high-value molecules, compounds and rare ingredients. CB Therapeutics has developed a patent-pending platform for creating and annotating libraries of biosynthetic pathway genes from next generation sequencing data. Processing and analyzing large amounts…
Details